Learn Mode

A - Agilent Technologies Inc

70

$110.24

-$3.24 (-2.855%)

At close: 3/27/26, 8:00 PM

3.55/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

A

Valuation Score

View as %

Stock Unlock

1D

1W

1M

YTD

1Y

3Y

5Y

Max

Stock Profile

Market Cap

$31.15B

Industry

Life Sciences Tools & Services

EPS (TTM)

$4.53

P/E (TTM)

24.15

Div & Yield

$1.02 (0.93%)

FCF Payout Ratio

29.03%

P/S (TTM)

4.41

P/B

4.51

Diluted Shares

284.00M

Ex-Dividend

2026-03-31

Next Earnings

05-26

Forward P/E

18.10

Payout Ratio

22.35%

P/FCF (TTM)

31.37

FCF Yield

3.19%

Earnings Yield

4.14%

52 Week Range

Score Card

Explore Scores Tab

3.55

Good

Agilent Technologies Inc has grown revenue at 8.14% over the past year, which suggests sales are increasing. Also, it has seen its diluted average shares outstanding decrease by -1.05% over the past year, which suggests the company is buying back shares.

Valuation Model

Key Score

3.00

Average

Management

4.00

Good

Growth

2.00

Bad

Profitability

3.00

Average

Fin. Health

1.00

Very Bad

Dividends

2.00

Bad

Analyst

5.00

Very Good

Insider Transactions

Explore Insider Tab

Buy

Sell

Market News

Page 1 of 21

11 new filings were in the last 7 days

Filter Form Types

Form SCHEDULE 13G/A

Unknown Form Type

Filed on 2026-03-26 15:12:29

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:39:21

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:36:00

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:29:59

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:27:06

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:26:13

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:09:50

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:06:51

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:05:49

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:05:07

Form 4

Statement of changes in beneficial ownership of securities - general instructions

Filed on 2026-03-23 16:03:07

Form 8-K

Current report pursuant to Section 13 or 15(d)

Filed on 2026-03-20 16:05:09

Page 1 of 21

Financials

Explore Financials Tab

Revenue

Earnings

Free Cash Flow

Price Targets

Go to Analyst Tab

These are one year price targets for: 2027-02-21

High:

$194.25

76.2%

Avg:

$171.65

55.7%

Low:

$151.50

37.4%

(% change is relative to the current stock price: $110.24)

Analyst Recommendations

Go to Analyst Tab

3.93

Good

21%

Strong Buy (6)

52%

Buy (15)

28%

Hold (8)

0%

Sell (0)

0%

Strong Sell (0)

About

Website
https://www.agilent.com/
Address
5301 Stevens Creek Blvd, Santa Clara CALIFORNIA, US
SEC Reports
https://sec.gov/edgar/browse/?CIK=1090872

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. The company is headquartered in Santa Clara, California and currently employs 18,000 full-time employees. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. Life Sciences and Diagnostics Markets segment comprises seven areas of activity. The company offers active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. Agilent CrossLab segment offers a services and consumables portfolio that spans the entire lab, in addition to software and laboratory automation solutions, which are designed to enhance customer outcomes. Applied Markets segment offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products.

IPO Date

1999-11-18

Industry

Life Sciences Tools & Services

Total Employees

18,000

Exchange

New York Stock Exchange, Inc.

Reporting Currency

USD

GICS

Life Sciences Tools & Services

GICS Sub

Life Sciences Tools & Services

GICS Sector

Health Care

GICS Group

Pharmaceuticals, Biotechnology & Life Sciences